- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Blood Irradiation market will register a 4.9% CAGR in terms of revenue, the global market size will reach $ 57 million by 2025, from $ 47 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Blood Irradiation business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Irradiation market by type, application, key manufacturers and key regions and countries.
This study considers the Blood Irradiation value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
X-ray Blood Irradiation
Gamma-ray Blood Irradiation
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Blood Bank
Hospital
Research Institutions
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Wuhan HNC Technology Co., Ltd.
Rad Source
Wenzhou Gengsheng Health Medical Equipment Co., Ltd.
STS Steuerungstechnik + Strahlenchutz GmbH
Best Theratronics
O3Vets
Gamma-Service
Hitaci
Cegelec
Gilardoni
JL SHEPHERD & ASSOCIATES
CIF medical
NPIC
Shinva Medical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Blood Irradiation consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Blood Irradiation market by identifying its various subsegments.
Focuses on the key global Blood Irradiation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Blood Irradiation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Blood Irradiation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood Irradiation Consumption 2015-2025
2.1.2 Blood Irradiation Consumption CAGR by Region
2.2 Blood Irradiation Segment by Type
2.2.1 X-ray Blood Irradiation
2.2.2 Gamma-ray Blood Irradiation
2.3 Blood Irradiation Consumption by Type
2.3.1 Global Blood Irradiation Consumption Market Share by Type (2015-2020)
2.3.2 Global Blood Irradiation Revenue and Market Share by Type (2015-2020)
2.3.3 Global Blood Irradiation Sale Price by Type (2015-2020)
2.4 Blood Irradiation Segment by Application
2.4.1 Blood Bank
2.4.2 Hospital
2.4.3 Research Institutions
2.5 Blood Irradiation Consumption by Application
2.5.1 Global Blood Irradiation Consumption Market Share by Type (2015-2020)
2.5.2 Global Blood Irradiation Value and Market Share by Type (2015-2020)
2.5.3 Global Blood Irradiation Sale Price by Type (2015-2020)
3 Global Blood Irradiation by Company
3.1 Global Blood Irradiation Sales Market Share by Company
3.1.1 Global Blood Irradiation Sales by Company (2018-2020)
3.1.2 Global Blood Irradiation Sales Market Share by Company (2018-2020)
3.2 Global Blood Irradiation Revenue Market Share by Company
3.2.1 Global Blood Irradiation Revenue by Company (2018-2020)
3.2.2 Global Blood Irradiation Revenue Market Share by Company (2018-2020)
3.3 Global Blood Irradiation Sale Price by Company
3.4 Global Blood Irradiation Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Blood Irradiation Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Blood Irradiation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Blood Irradiation by Regions
4.1 Blood Irradiation by Regions
4.2 Americas Blood Irradiation Consumption Growth
4.3 APAC Blood Irradiation Consumption Growth
4.4 Europe Blood Irradiation Consumption Growth
4.5 Middle East & Africa Blood Irradiation Consumption Growth
5 Americas
5.1 Americas Blood Irradiation Consumption by Countries
5.1.1 Americas Blood Irradiation Consumption by Countries (2015-2020)
5.1.2 Americas Blood Irradiation Value by Countries (2015-2020)
5.2 Americas Blood Irradiation Consumption by Type
5.3 Americas Blood Irradiation Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Blood Irradiation Consumption by Regions
6.1.1 APAC Blood Irradiation Consumption by Regions (2015-2020)
6.1.2 APAC Blood Irradiation Value by Regions (2015-2020)
6.2 APAC Blood Irradiation Consumption by Type
6.3 APAC Blood Irradiation Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Blood Irradiation by Countries
7.1.1 Europe Blood Irradiation Consumption by Countries (2015-2020)
7.1.2 Europe Blood Irradiation Value by Countries (2015-2020)
7.2 Europe Blood Irradiation Consumption by Type
7.3 Europe Blood Irradiation Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Blood Irradiation by Countries
8.1.1 Middle East & Africa Blood Irradiation Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Blood Irradiation Value by Countries (2015-2020)
8.2 Middle East & Africa Blood Irradiation Consumption by Type
8.3 Middle East & Africa Blood Irradiation Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Blood Irradiation Distributors
10.3 Blood Irradiation Customer
11 Global Blood Irradiation Market Forecast
11.1 Global Blood Irradiation Consumption Forecast (2021-2025)
11.2 Global Blood Irradiation Forecast by Regions
11.2.1 Global Blood Irradiation Forecast by Regions (2021-2025)
11.2.2 Global Blood Irradiation Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Blood Irradiation Forecast by Type
11.8 Global Blood Irradiation Forecast by Application
12 Key Players Analysis
12.1 Wuhan HNC Technology Co., Ltd.
12.1.1 Company Information
12.1.2 Blood Irradiation Product Offered
12.1.3 Wuhan HNC Technology Co., Ltd. Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Wuhan HNC Technology Co., Ltd. Latest Developments
12.2 Rad Source
12.2.1 Company Information
12.2.2 Blood Irradiation Product Offered
12.2.3 Rad Source Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Rad Source Latest Developments
12.3 Wenzhou Gengsheng Health Medical Equipment Co., Ltd.
12.3.1 Company Information
12.3.2 Blood Irradiation Product Offered
12.3.3 Wenzhou Gengsheng Health Medical Equipment Co., Ltd. Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Wenzhou Gengsheng Health Medical Equipment Co., Ltd. Latest Developments
12.4 STS Steuerungstechnik + Strahlenchutz GmbH
12.4.1 Company Information
12.4.2 Blood Irradiation Product Offered
12.4.3 STS Steuerungstechnik + Strahlenchutz GmbH Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 STS Steuerungstechnik + Strahlenchutz GmbH Latest Developments
12.5 Best Theratronics
12.5.1 Company Information
12.5.2 Blood Irradiation Product Offered
12.5.3 Best Theratronics Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Best Theratronics Latest Developments
12.6 O3Vets
12.6.1 Company Information
12.6.2 Blood Irradiation Product Offered
12.6.3 O3Vets Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 O3Vets Latest Developments
12.7 Gamma-Service
12.7.1 Company Information
12.7.2 Blood Irradiation Product Offered
12.7.3 Gamma-Service Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Gamma-Service Latest Developments
12.8 Hitaci
12.8.1 Company Information
12.8.2 Blood Irradiation Product Offered
12.8.3 Hitaci Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Hitaci Latest Developments
12.9 Cegelec
12.9.1 Company Information
12.9.2 Blood Irradiation Product Offered
12.9.3 Cegelec Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Cegelec Latest Developments
12.10 Gilardoni
12.10.1 Company Information
12.10.2 Blood Irradiation Product Offered
12.10.3 Gilardoni Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Gilardoni Latest Developments
12.11 JL SHEPHERD & ASSOCIATES
12.11.1 Company Information
12.11.2 Blood Irradiation Product Offered
12.11.3 JL SHEPHERD & ASSOCIATES Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 JL SHEPHERD & ASSOCIATES Latest Developments
12.12 CIF medical
12.12.1 Company Information
12.12.2 Blood Irradiation Product Offered
12.12.3 CIF medical Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 CIF medical Latest Developments
12.13 NPIC
12.13.1 Company Information
12.13.2 Blood Irradiation Product Offered
12.13.3 NPIC Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 NPIC Latest Developments
12.14 Shinva Medical
12.14.1 Company Information
12.14.2 Blood Irradiation Product Offered
12.14.3 Shinva Medical Blood Irradiation Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Shinva Medical Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Blood Irradiation Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of X
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
